A303360 logo

Protia Inc. Stock Price

KOSDAQ:A303360 Community·₩53.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A303360 Share Price Performance

₩4,115.00
795.00 (23.95%)
₩4,115.00
795.00 (23.95%)
Price ₩4,115.00

A303360 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks
2 Rewards

Protia Inc. Key Details

₩16.2b

Revenue

₩6.3b

Cost of Revenue

₩10.0b

Gross Profit

₩5.2b

Other Expenses

₩4.7b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
367.66
61.42%
29.15%
0%
View Full Analysis

About A303360

Founded
2000
Employees
n/a
CEO
Kook Jin Lim
WebsiteView website
www.protia.co.kr

Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Recent A303360 News & Updates

Analysis Article May 21

Protia's (KOSDAQ:303360) Promising Earnings May Rest On Soft Foundations

Despite posting some strong earnings, the market for Protia Inc.'s ( KOSDAQ:303360 ) stock hasn't moved much. Our...

Recent updates

No updates